Skip to main content
Balaji Amines Ltd. logo

Balaji Amines Ltd. — Investor Relations & Filings

Ticker · BALAMINES ISIN · INE050E01027 LEI · 3358009DS8RG4Z8QBD69 BSE.NS Manufacturing
Open in API
Filings indexed 741 across all filing types
Latest filing 2026-05-23 Call Transcript
Country IN India
Listing BSE.NS BALAMINES

About Balaji Amines Ltd.

https://www.balajiamines.com/

Balaji Amines Ltd. is a leading manufacturer specializing in Aliphatic Amines, their derivatives, and specialty chemicals. The company produces a diverse range of products, including Methylamines, Ethylamines, and specialty chemicals such as N-Methyl-2-Pyrrolidone (NMP), Morpholine, Dimethylformamide (DMF), and Gamma-Butyrolactone (GBL). Its portfolio serves critical sectors including pharmaceuticals, agrochemicals, refineries, water treatment, and personal care. Utilizing advanced manufacturing technologies and vertically integrated processes, the company maintains a significant market presence in the production of amines and downstream derivatives. Balaji Amines is recognized for its large-scale production capacity and its role as a key supplier of essential chemical intermediates used in the synthesis of active pharmaceutical ingredients and crop protection chemicals.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 90% confidence The document is the full verbatim transcript of Balaji Amines Limited’s Q4 FY26 earnings conference call, including moderator introductions, management remarks, and Q&A. It clearly matches the definition of a Call Transcript (conference call with Q&A).
2026-05-23 English
Submission of Earning Call Transcript under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Call Transcript Classification · 92% confidence The document is a submission to stock exchanges enclosing the full Q4 FY26 earnings conference call transcript. It contains the complete call transcript with management’s presentation, Q&A, and detailed financial commentary, which matches the definition of a Call Transcript (CT).
2026-05-23 English
Copy of Newspaper Publication
Regulatory Filings Classification · 85% confidence The document is a compliance notice under SEBI LODR Regulations filing with stock exchanges enclosing copies of a shareholder notice about mandatory transfer of shares to the IEPF. It does not contain financial results, board changes, dividends declaration, or AGM materials, nor is it a report itself. It is a regulatory announcement/falling‐back miscellaneous filing, so it best matches Regulatory Filings (RNS).
2026-05-22 English
Notice of Transfer of Equity shares of the Company to Investor Education and Protection Fund
Regulatory Filings Classification · 88% confidence The document is a formal disclosure submitted to BSE and NSE under SEBI Listing Regulations (Regulation 30, 47) enclosing copies of a mandatory shareholder notice regarding the transfer of unclaimed dividends and shares to the Investor Education and Protection Fund (IEPF). It is a compliance announcement, not an actual financial report, dividend declaration notice, or meeting-related filing. It falls under general regulatory announcements to exchanges. Therefore it is classified as a Regulatory Filing (RNS).
2026-05-22 English
Commencement of commercial production/operations
Regulatory Filings Classification · 90% confidence The document is a formal intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) to BSE and NSE regarding the commissioning of a new Dimethyl Ether plant. It is a regulatory announcement of a material event/operational update and does not contain financial statements or voting materials. It therefore falls under general regulatory filings.
2026-05-20 English
Intimation of Commissioning of Commercial Production of Dimethyl Ether (DME) and Press Release.
Regulatory Filings Classification · 90% confidence The document is an official intimation letter sent under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to the stock exchanges, disclosing the commissioning of a new Dimethyl Ether (DME) plant. It is a regulatory announcement of a material event (commercial production commencement), not a financial report, earnings release, AGM materials, or any other specific filing category. Therefore it falls under general regulatory filings (RNS).
2026-05-20 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.